
Camlin Fine Sciences ranks 27th by market capitalisation among 44 Specialty Chemicals companies tracked by ATS. Its largest peers are Pidilite Industries, Gujarat Fluorochemicals and Navin Fluorine International. Its P/E of 22.5 compares with a peer median of 39.4.
Sorted by market capitalisation.
| Company | Close (₹) | 1D | Market cap (₹ cr) | P/E | P/B | ROE | 1Y return |
|---|---|---|---|---|---|---|---|
| Pidilite Industries | 1,493.30 | -1.79% | 1,51,983 | 57.4 | 14.03 | 23.8% | +12.5% |
| Gujarat Fluorochemicals | 4,568.20 | -0.20% | 50,182 | 81.9 | 6.38 | 7.6% | +12.5% |
| Navin Fluorine International | 8,517.50 | -0.22% | 43,651 | 55.3 | 10.98 | 20.1% | +12.5% |
| Aether Industries | 1,795.30 | -0.25% | 23,820 | 101.3 | 9.70 | 9.4% | +12.5% |
| Deepak Nitrite | 1,548.00 | -0.81% | 21,114 | 27.0 | 3.62 | 9.8% | +12.5% |
| Aarti Industries | 489.40 | +1.71% | 17,745 | 33.4 | 2.98 | 7.3% | +12.5% |
| Atul | 5,942.00 | -0.97% | 17,494 | 22.0 | 2.81 | 11.5% | +12.5% |
| Fine Organic Industries | 5,625.50 | +1.60% | 17,248 | 39.4 | 6.47 | 16.8% | +12.5% |
| BASF India | 3,453.40 | -0.54% | 14,948 | 23.3 | 3.78 | 11.1% | +12.5% |
| Privi Speciality Chemicals | 3,524.20 | +0.55% | 13,766 | 39.4 | 9.75 | 26.0% | +12.5% |
| Camlin Fine Sciences | 94.55 | -0.47% | 1,816 | 22.5 | 1.74 | 2.8% | — |
Source: NSE end-of-day prices; ratios from company filings. Data as of 7 October 2026. How this data is compiled.
Camlin Fine Sciences' listed peers in Specialty Chemicals include Pidilite Industries, Gujarat Fluorochemicals, Navin Fluorine International, Aether Industries, Deepak Nitrite and Aarti Industries, ranked here by market capitalisation.
Camlin Fine Sciences trades at a P/E of 22.5, against a median of 39.4 across the 10 Specialty Chemicals peers shown.
By market capitalisation, the largest company in the group is Pidilite Industries at ₹1.52 lakh crore, against ₹1,816 crore for Camlin Fine Sciences.
Track CAMLINFINE live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.